Shareholders Sue Dicerna Pharmaceuticals Over Proposed Merger
Plaintiffs Laurie Volpe and Matthew Hopkins have filed suit separately against defendant Dicerna Pharmaceuticals, Inc. (Dicerna), and their board of
Stay updated with breaking news from Marc Kozin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Plaintiffs Laurie Volpe and Matthew Hopkins have filed suit separately against defendant Dicerna Pharmaceuticals, Inc. (Dicerna), and their board of
Share this article Share this article ST. PETERSBURG, Fla., June 3, 2021 /PRNewswire/ -- Isleworth Healthcare Acquisition Corp. (NASDAQ: ISLE) (the "Company") announced today announced that on May 28, 2021 it received a notice ("Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule") because the Company failed to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2021 (the "Form 10-Q") with the Securities and Exchange Commission ("SEC"). Th...
Share this article Share this article ST. PETERSBURG, Fla., March 2, 2021 /PRNewswire/ -- Isleworth Healthcare Acquisition Corp. (NASDAQ: ISLEU) (the "Company") announced today the closing of its initial public offering of 20,700,000 units, which included the full exercise of the underwriters' over-allotment option, at a price to the public of $10.00 per unit. The units began trading on the Nasdaq Capital Market under the symbol "ISLEU" on February 25, 2021. Each unit consists of one share of common stock and one-half of one redeemable warrant. Each whole warrant entitles the holder to purch...